Terpenes and Testing: The Podcast

On this episode, Dr. Lupoi chats with neuroscientist Dr. Michelle Ross. Discussion points include Dr. Ross’s advocacy of cannabis for treating chronic pain, truths and fallacies regarding cannabis & motherhood, and the medicinal uses of kratom, another taboo, ethnobotanical plant with considerable therapeutic promise.
In this episode, Jason S. Lupoi, Ph.D. chats with multi-Emerald Cup award-winning cannabis farmer and breeder, Karla Avila, who co-founded Flowerdaze Farm with her husband. Discussion topics include regenerative farming, terroir (aka “taste the place”), cultivating companion plants, maximizing scarce water resources, and creating a living, thriving ecosystem on your farm. 
In this episode, Jason S. Lupoi, Ph.D. chats with Derek Chase, president of Flora + Bast Cannabis and founder of Psilouette Wellbeing. Discussion points include the stoned ape theory and the idea that psilocybin may have birthed language; why we are pointed towards addictive things like caffeine, TV, and sugar, whereas substances like cannabis and…
On this episode, Jason S. Lupoi, Ph.D. chats with Robert Strongin, Ph.D., Professor of Organic Chemistry at Portland State University. Drs. Lupoi and Strongin discuss toxicants that can form as terpene degradation products when dabbing at high temperatures, how the levels of these toxicants compare to those formed from smoking a joint, breathing nanoparticles, and…
On this episode, Jason S. Lupoi, Ph.D. chats with Steve Scheier, “leadership cultivator” and co-author of the book Power Up: Power Tools for Committed Cannabusiness Leaders. Discussion points include how to effectively find your inner power to help facilitate stepping into a leadership role within the cannabis industry, challenges new managers can face, why your…
In our inaugural podcast episode, T&T editor-in-chief, Jason S. Lupoi, Ph.D., chats with Dr. Bryan Doner, President/CEO of D&P Medical Group. Drs. Doner and Lupoi discuss the endocannabinoid system and its omission in the modern medical school curriculum, Dr. Doner’s personal interest in cannabis-based medicine, and the reaction of some of Dr. Doner’s peers when…